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ABSTRACT  Uptake of benzo(a)pyrene by living cultured cells has been visualized in real time 
using digital fluorescence-imaging microscopy. Benzo(a)pyrene  was noncovalently associated 
with  lipoproteins,  as a physiologic  mode of presentation of the carcinogen  to cells.  When 
incubated  with  either  human  fibroblasts  or  murine  P388D1 macrophages,  benzo(a)pyrene 
uptake occurred in the absence of endocytosis, with a halftime of ~2 min, irrespective of the 
identity of the delivery vehicles, which were high density lipoproteins, low density lipoproteins, 
very low density lipoproteins, and 1-palmitoyl-2-oleoylphosphatidylcholine single-walled ves- 
icles.  Thus,  cellular  uptake  of  benzo(a)pyrene  from  these  hydrophobic  donors  occurs  by 
spontaneous transfer through the aqueous phase. Moreover, the rate constant for uptake, the 
extent of uptake, and the intracellular localization of benzo(a)pyrene were identical for both 
living and fixed cells. Similar rate constants for benzo(a)pyrene efflux from cells to extracellular 
lipoproteins suggests the involvement of the plasma membrane in the rate-limiting step. The 
intracellular  location  of  benzo(a)pyrene  at  equilibrium  was  coincident  with  a  fluorescent 
cholesterol  analog,  N-(7-nitrobenz-2-oxa-1,3-diazole)-23,24-dinor-5-cholen-22-amine-313-ol. 
Benzo(a)pyrene did not accumulate in acidic compartments,  based on acridine orange  fluo- 
rescence,  or in mitochondria,  based on rhodamine-123 fluorescence. When the intracellular 
lipid volume of isolated mouse peritoneal macrophages  was increased  by prior incubation of 
these cells with either acetylated low density lipoproteins or with very low density lipoproteins 
from  a  hypertriglyceridemic  individual,  cellular  accumulation  of  benzo(a)pyrene  increased 
proportionately  with  increased  [1-14C]oleate  incorporation  into  cellular  triglycerides  and 
cholesteryl esters. Thus, benzo(a)pyrene uptake by cells is a simple  partitioning phenomenon, 
controlled  by the relative lipid volumes of extracellular donor lipoproteins and of cells,  and 
does not involve lipoprotein endocytosis as an obligatory step. 
Benzo(a)pyrene is a common environmental pollutant whose 
carcinogenic potential depends on oxidative metabolism after 
cellular uptake (1). Oxygenation and hydration reactions oc- 
cur in the endoplasmic reticulum to form active carcinogenic 
compounds, such as diol expoxides, that interact covalently 
with DNA. Most investigations have been concerned with the 
enzymatic events  of cytochrome P45o-dependent  metabolic 
processes, and with the chemical modification of DNA.  In 
vivo, these processes are necessarily preceded by cellular up- 
take of  the hydrophobic precursor hydrocarbon (2). Typically, 
metabolic studies of benzo(a)pyrene are performed by expos- 
ing cells or microsomal fractions to concentrated solutions of 
benzo(a)pyrene in  organic solvents diluted  into the culture 
medium or the reaction mixture. Because of the low aqueous 
solubility of benzo(a)pyrene, -10  -8 M (3), little of the hydro- 
carbon is truly in solution under these conditions and most, 
if not  all,  is present  in  the  form of microcrystals (4).  The 
kinetics of desorption of benzo(a)pyrene from microcrystals 
to  lipid  bilayers  is  slow  (5).  Because  solubilization  of 
benzo(a)pyrene in microsomal membranes is obligatory for 
its  further  metabolism,  this  experimental  procedure  most 
likely leads  to  significant  underestimation  of the  rate  and 
extent of metabolism, because there is limited incorporation 
of benzo(a)pyrene into microsomal preparations or cell mem- 
branes. 
A physiologic mode of presentation of these hydrophobic 
compounds is as a solubilized component of a lipid matrix. 
Studies  in  vitro  (6,  7)  and  in  vivo  (8)  have  shown  that 
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are present in the plasma as noncovalent components of the 
plasma  lipoproteins.  The plasma  lipoproteins are dynamic 
macromolecular assemblies  of lipids and specific apoproteins 
and differ in size, density, chemical composition, and meta- 
bolic  fate  (9,  10). In  fasting  plasma,  the  most  abundant 
lipoproteins  are  the  protein-rich  high  density  lipoproteins 
(HDL), j which contain about 25 mol% phosphatidylcholine 
and 50 moi% protein. Low density lipoproteins (LDL) con- 
tain  37  mol%  cholesteryl ester,  whereas  very low  density 
lipoproteins (VLDL) are 50 mol% triglyceride. Apolipopro- 
tein B (ApoB) a protein component of LDL, is recognized by 
specific high-affinity  membrane sites on certain cells for re- 
ceptor-mediated endocytosis (1 I). Thus, uptake of LDL by 
these  receptors could  introduce  benzo(a)pyrene and  other 
xenobiotics into the cell interior as components of the lipo- 
protein. 
The lipids and most of the protein components of lipopro- 
teins  exchange  rapidly  among  lipoprotein  classes  (9,  10). 
Benzo(a)pyrene transfer between LDL is relatively fast, with 
a  halftime of ~200  ms  (12).  Many  factors are  known  to 
influence the rates and energetics of spontaneous desorption 
of lipophiles such as fatty acids, phospholipids, and polycyclic 
aromatic hydrocarbons from a  phospholipid surface. These 
include  the  length  of acyl  chains  (13),  the  nature  of the 
hydrophilic headgroup (13-15), the molecular surface area of 
aromatic compounds  (16),  the  nature  of the  hydrophobic 
environment (17,  18), and the radius of the lipid surface from 
which desorption occurs (19). 
Evidence that cellular uptake of benzo(a)pyrene from li- 
poproteins occurs by transfer of individual molecules through 
the  aqueous  solution  has  been  obtained  by  Remsen  and 
Shireman (20), who have demonstrated with LDL receptor- 
negative cells that cellular uptake of  benzo(a)pyrene can occur 
in the absence of LDL endocytosis. These studies,  however, 
did  not  address  the  kinetics  of  passive  transfer  of 
benzo(a)pyrene, or the potential contribution in normal cells 
of either receptor-mediated endocytosis or fluid-phase endo- 
cytosis of the lipoprotein carrier. Clarification of these aspects 
of the dynamics of cellular uptake of benzo(a)pyrene and the 
mechanism of intracellular and intercellular distribution of 
benzo(a)pyrene is necessary to understand the overall process 
of benzo(a)pyrene carcinogenesis. Thus, one objective of this 
study  was  to  examine  the  mechanism  and  kinetics  of 
benzo(a)pyrene entry into cells by direct observation of living 
cells in real time using digital  fluorescence-imaging micros- 
copy. A  second  objective was  to  determine the  effects  of 
lipoprotein metabolism on the extent of cell uptake and on 
intracellular distribution  of benzo(a)pyrene. An  abstract of 
this work has been published (21 ). 
MATERIALS  AND  METHODS 
Fluorescence Microscopy:  The  digital  fluorescence-imaging  mi- 
croscopy system is described in detail  in the preceding article (22). Briefly, the 
system consisted ofa Leitz  Diavert inverted fluorescence microscope (E. Leitz, 
Inc., Rockleigh,  N J), a  Hamamatsu Vidicon C1000-12  low light level camera 
(Hamamatsu  Corp.,  Middlesex,  NJ),  and  a  Grinnell  274  image  processor 
~  Abbreviations  used  in  this paper." acLDL,  acetylated  low  density 
lipoprotein;  DiI,  1,1'-dioctadecyi-3,3,3',3'-tetramethylindocarbocy- 
anine;  HDL,  high  density  iipoproteins;  htg;  hypertriglyceridemic; 
LDL,  low density  lipoproteins;  NBD-cholesterol,  N-(7-nitrobenz-2- 
oxa-l,3-diazole)-23,24-dinor-5-cholen-22-amine-3B-ol;  VLDL,  very 
low density lipoprotein. 
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(Grinnell Systems Corp., San Jose, CA) with three separate 512  x  480  8-bit 
memory planes. A Lab Datex LSI I 1/23 minicomputer (Data Translation, Inc.. 
Marlboro,  MA)  was interfaced  through a  Q-bus to  the  image  processor, a 
Charles River (Charles River Data Systems, Inc., Framingham, MA) 20 Mbyte 
hard disk and a Cipher F880 magnetic tape (Cipher Data Products Inc., San 
Diego,  CA)  for archival  storage.  Photographs of the  Grinnell  images were 
produced with a  Matrix  Instruments 35-mm color graphic recorder (Matrix, 
Inc., Mesa, AZ). 
Cells were cultured as described below on 22-cm  2 x 0.17-mm glass coverslips 
in tissue culture dishes, and were transferred to  Bionique culture  chambers 
(Bionique, Coming, Lake Placid,  NY) for experiments on the microscope. Live 
cells were maintained on the microscope stage at constant temperature (37* _+ 
I'C) with constant infusion of 5% CO2. Cellular fluorescence was measured for 
I s at intervals of 30 s or l min. Typical fields contained one to three fibroblasts 
and  12-20  macrophages. Single  frames were digitized  in 33  ms. To increase 
the signal-to-noise ratio, each image that was stored was an integration of 32 
frames acquired at 30 Hz. To avoid photofading, excitation light was reduced 
with neutral-density  filters.  The absence of photofading was verified  by rate 
constant maps (22).  In the microscope field of l I l  x  128 ~m, pixel  size was 
-0.0625  #m 2  at  the  magnification  used  for  this  study.  Time  lapse  video 
recording of the phase-contrast images allowed evaluation of viability  of cells 
by the saltatory movement of the phase-dense lysosomes (23). 
Lipoprotein  Preparation:  Lipoproteins were isolated  from normal 
human plasma by ultracentrifugation (24) at the following densities:  normal 
VLDL,  p  <  1.006;  LDL,  p  1.019-1.063;  HDL,  p  1.063-1.21.  Lipoprotein- 
deficient  serum was prepared from the fraction with p >  1.21. Hypertriglyceri- 
demic VLDL (htg VLDL) with an Sf of 100-400 was prepared from plasma of 
a type IV individual by flotation (25).  Acetylated LDL (acLDL) was prepared 
as described by Basu et al. (26). Lipoproteins were labeled with benzo(a)pyrene, 
[G-3H]benzo(a)pyrene,  or  N-(7-nitrobenz-2-oxa-l,3-diazole)-23,24-dinor-5- 
cholen-22-amine-3/3-ol  (NBD-cholesterol) (27) by drying organic solutions of 
the fluorophore on 200-#m glass beads (Polysciences,  Inc., Warrington, PA), 
and incubating the lipoprotein preparation with the beads overnight at 37"C. 
Approximately 0.2 pmol of benzo(a)pyrene was incorporated per milligram of 
LDL protein, which is equivalent to an average of 100 benzo(a)pyrene mole- 
cules per LDL.  Benzo(a)pyrene content of labeled  of HDL and  VLDL was 
0.017  and  0.1  pmol.mg  -~  apoprotein,  or  an  average  of  1.7  and  60 
benzo(a)pyrene molecules per lipoprotein, respectively.  Benzo(a)pyrene labeling 
was quantified by optical density measurements on a Cart  15 speetrophotom- 
eter using an extinction coetficient  of 6 ×  104 M -~.cm  -j at 365 nm (28).  LDL 
and  HDL were labeled  with  l,l'-dioctadecyl-3,3,3',3'-tetramethylindocarbo- 
cyanine  (dil)  as  described  (29).  Lipoproteins  labeled  with  both  dil  and 
benzo(a)pyrene were  labeled  initially  with  diI,  and  then  were  labeled  with 
benzo(a)pyrene. 
Cell Culture:  All cells were maintained at 37"C and 5% CO2. Normal 
human fibroblasts were prepared from human foreskin explants and cultured 
in  Dulbecco's modified  Eagle's medium  containing  10%  fetal  calf serum,  1 
mM  glutamine,  and  50  ~g.ml  -]  penicillin/streptomycin.  To  induce  LDL 
receptor expression, fetal  calf serum was replaced  with  human lipoprotein- 
deficient serum for 2 days (l 1). C3H/10T 1/2 murine fibroblasts were obtained 
from the American Type Culture Collection and cultured in Dulbecco's me- 
dium supplemented with  10% fetal calf serum, I mM glutamine, and 50 #g. 
ml  -~ penicillin/streptomycin. Cells were passaged before reaching confluence 
and were used between the  7th and the  I lth  passage. The P388DI  murine 
macrophage cell line was obtained from the Salk Institute Cell Repository and 
was cultured in RPMI-1640 medium supplemented with 10% fetal calf serum, 
l  mM glutamine, and 50 ~g.ml  -~ penicillin/streptomycin. Mouse peritoneal 
macrophages were isolated  from Balb/c  mice by peritoneal  lavage.  Isolated 
macrophages were cultured for 2 d under the conditions used for the continuous 
macrophage line. 
Fluorescence  Labeling of Cells:  Benzo(a)pyrene was purchased 
from Aldrich Chemicals (Milwaukee, WI) and purified by thin-layer chroma- 
tography on silica gel in isooctane/ether/acetic acid (75:25:2,  vol/vol/vol), or 
by reversed phase octadecyl-silica  high-pressure liquid chromatography in 80% 
acetonitrile.  DiI and  rhodamine-123  were obtained  from  Molecular  Probes 
(Junction City,  OR), and acridine orange was purchased from Polysciences, 
Inc. The synthesis of NBD-cholesterol has been described (27). Live fibroblasts 
previously incubated with benzo(a)pyrene were exposed to 5 #g.ml  -~ rhoda- 
mine-123 for 30 min at 37"C. Cells were placed in fresh medium for l0 min, 
transferred to the stage of the microscope, and viewed immediately. Rhodamine 
fluorescence was observed using a 560-rim band-pass filter for excitation and a 
575-nm cut-on filter  for emission. Acridine orange was added to live cells on 
the stage at a final concentration of 5 pg. ml  -I. After 2 min, cells were rinsed 
twice with fresh medium and fixed.  Acridine orange fluorescence was viewed 
immediately with a 480-nm bandpass plus a 495-nm cutoff filter for excitation 
and a  510-nm cut-on emission filter.  Because of organelle movement in live cells,  fixation  of cells  after  labeling  with acridine  orange  was required  for 
colocalization studies. Gross cellular morphology was unchanged as a result of 
fixation, and the intracellular location of acridine orange, but not rhodamine- 
123, was identical before and for ~20 rain after fixation. 
NBD-cholesterol was added to fixed cells as a component of LDL for 12-24 
h  before  viewing.  For  double-label  experiments,  cell  were  exposed  to 
benzo(a)pyrene after labeling with NBD-cholesterol. NBD-cholesterol fluores- 
cence was visualized through the same filter  combination as acridine orange. 
For all double-label experiments, control ceils labeled with one of each fluorop- 
bore were examined to quantify the appearance of fluorescence through the 
filter  combination used for the other fluorophore. Control cells without any 
label were also examined for autofluorescence. Neutral-density filters were used 
to attenuate excitation light so that contributions from autofluoreseence and/ 
or fluorescence from the second fluorophore were below the limits of detection. 
Thus, the fluorescence intensity in any of the filter combinations was from 
emission of a single fluorophore. To establish limits of detection and the range 
of linear  camera  response,  1  ml  of ethanolic  solutions of benzo(a)pyrene, 
ranging from 0.1  to 200 uM, was added to the culture chamber. Excitation 
light was attenuated to 1% of maximum intensity for all samples except for the 
150 and 200 uM samples, for which excitation light was attenuated to 0.4%. 
Fluorescence intensities of ethanolic solutions ofdil, NBD-cholesterol, acridine 
orange, and rhodamine- 123 concentrations were linear between 0.1 ~M- 1 raM, 
0.1-80 uM; 0.1-50/~M;  0.1-100 #M, respectively.  Excitation light was atten- 
uated from 0 to 96.6%. The system response was a linear function of concen- 
trations over this range. 
The relation between fluorescence emission and intensity of excitation light 
is If =  Io x  4~(1 -  e-a), where If is the fluorescence intensity; Io, the intensity 
of excitation  light;  ~, quantum efficiency;  ~,  molar extinction coefficient;  c, 
concentration; and /, pathlength of the sample. Because the pathlength of a 
lipid  inclusion  is  small,  <10  t,m,  the  exponential  term  is  small  even  at 
concentrations >500 ~M.  When the fraction of light absorbed is very small, 
such that ~cl is <0.05, the fluorescence intensity is linear with concentration 
(30)  and  with  mass  (31).  Even  at  concentrations  >120  ~M,  fluorescence 
intensity in this system is proportional to mass, because of the front surface 
emission. Based on comparison of intensities of the standard solutions with 
intracellular fluorescence intensities, typical intracellular benzo(a)pyrene con- 
centrations measured by digital  fluorescence microscopy range appear to be 
within the linear range of the system response. 
Benzo(a)pyrene  Metabolism:  Normal  human  fibroblasts  and 
C3HI0/T Y2 murine fibroblasts were grown in parallel in 60-mm culture dishes 
until  nearly  confluent.  At  appropriate  times,  1 ml  of Dulbecco's medium 
containing 50 ug" ml  -t LDL labeled with [G-3Hlbenzo(a)pyrene was added per 
plate. Final concentration of benzo(a)pyrene per dish was 10 uM. All plates 
were harvested simultaneously. Media were removed, combined with 1 ml of 
a 0.15 M  NaCI rinse into tubes wrapped with aluminum foil, and lyophilized 
overnight. Cells were removed from dishes by scraping with a rubber policeman. 
Aliquots of cell  suspensions were taken  for protein determination  (32),  for 
scintillation counting, for calculation of recovery, and for extraction. A 0.5-ml 
volume of cell  suspension was extracted  twice with 5  ml  of ethyl  acetate/ 
acetone (2:1,  vol/vol). Extracts were dried under a  N2 stream, resolubilized, 
and applied to silica gel chromatogram sheets (Eastman Kodak Co., Rochester, 
NY) for separation of benzo(a)pyrene and metabolites. The solvent was hexane/ 
benzene (15:1,  vol/vol) (33).  In this system, benzo(a)pyrene migrates near the 
solvent front, while metabolites remain near the origin. The benzo(a)pyrene 
band was identified by fluorescence. Each strip was then cut into sections and 
counted. Radioactivity left in the cell residue after extraction was assumed to 
be covalently bound metabolites.  Media  samples were extracted,  chromato- 
graphed, and counted. Recovery O  f initial radioactivity was -90%. 
[14C]Oleate/[3H]Benzo(a)pyrene Incorporation:  Macro- 
phages were isolated from Balb/c mice by peritoneal lavage.  After incubation 
for 2  d  with either  50  ttg.ml  -t  LDL,  acLDL,  or htg VLDL in  Dulbecco's 
medium containing  10%  lipoprotein-deficient  serum and 0.15  mM  [1-t4C]  - 
oleate (sp act,  1.2 x  10  7 cpm .vmol  -t) complexed with bovine serum albumin 
(bovine serum albumin) (34) was added  to each plate.  After 38  h  at  37*(7, 
media were removed and cells were washed two times with 0.04 M  Tris, pH 
7.4, containing 0.15 M NaC1 and 5 rag. ml  -~ bovine serum albumin. Each plate 
was then incubated for 1 h  in medium containing  10%  lipoprotein-deficient 
serum and  100 t~g.ml  -~ LDL containing [G-3H]benzo(a)pyrene (sp act  1.3  x 
l08 cpm.t~mol-t). Cells were rinsed two times and then scraped into  1 ml of 
0.15  M  NaCI. Aliquots were taken for 3H and protein quantification and for 
extraction  of triglycerides  and  cholesteryl esters with  10  vols of hexane/2- 
propanol (3:2,  vol/vol). Extracts were taken to dryness, redissolved in hexane, 
and  chromatographed on Eastman silica  gel  chromatogram sheets in  2,2,4- 
trimethylpentane/ether/acetic acid (85:15:2,  vol/vol/vol). Lipids were visual- 
ized  with  /2  vapor,  and  the  appropriate  bands  were cut  out  and  counted. 
Macrophages on coverslips treated in parallel were fixed with 2% formaldehyde 
after treatment with benzo(a)pyrene. 
Kinetic  Measurements and  Analysis:  Kinetic  measurements, 
based on time-dependent changes in cellular fluorescence intensity, were made 
directly.  Fibroblasts  were grown  on  22-cm  2 No.  1 glass  eoverslips (Chase 
Instruments Corp.,  Poultney,  VT),  and  placed  in  a  teflon  culture  chamber 
designed for microscopy (Bionique, Corning, Lake Placid,  NY). A  plexiglass 
cover  fitted  with  a  stainless  steel  15-gauge  needle  allowed  perfusion  with 
humidified  5%  CO2.  Temperature control was achieved  by hot air curtains. 
Ports in the chamber cover allowed constant monitoring of temperature, as 
well  as  removal  and  addition  of media  to  cells  on  the  stage.  For kinetic 
experiments, the fluorescence of a single field of live or fixed cells was followed 
directly,  in  real  time,  after  the addition  of benzo(a)pyrene-labeled  LDL  in 
medium to the chamber to initiate cellular uptake. The field was monitored 
continually  by  phase  contrast  and  exposed  to  excitation  light  at  selected 
intervals. At each time point, phase and fluorescence images were digitized  and 
stored. 
Background fluorescence from the medium was not >5% greater than dark 
current values.  Because  of the large  numerical aperture (1.4)  and short depth 
of field (0.4 #m) of the x63 objective lens, cellular fluorescence was minimally 
affected  by fluorescence from labeled  lipoproteins in the medium. These con- 
ditions allowed  rapid,  real-time  measurements of the spatial distribution  of 
cellular fluorescence.  Therefore. cellular fluorescence measurements were not 
corrected for any contribution from the medium. 
To quantify cellular uptake of [G-3H]benzo(a)pyrene from lipoproteins, cells 
were separated from labeled lipoproteins by filtration through glass fiber filters. 
Filter assays were performed with fibroblasts suspended by trypsinization or 
with P388D~  cells  suspended by rinsing the plate with  medium. Cells were 
suspended in  1.5-2  ml of either 0.15  M  saline or culture  medium without 
serum.  Cell  suspensions were  stirred  constantly with  small  magnetic  bars. 
Temperature was measured with a  Bailey digital  thermometer (Bailey  Instru- 
ments Co., inc., Saddle Brook, MA). Small volumes of [G-3H]benzo(a)pyrene  - 
labeled  lipoproteins were added to cell suspensions. At appropriate intervals, 
50- or 100-#1 aliquots were removed, added to 5 ml of buffer solution containing 
0.15  M  NaCI, 0.04  M  Tris, 0.3  mM EDTA, and  5  mg-ml  -~ bovine serum 
albumin, and filtered.  Bovine serum albumin reduced  nonspecific binding of 
benzo(a)pyrene-labeled  LDL  to  the  filters.  For each  experiment,  a  solution 
containing  only  [G-3H]benzo(a)pyrene  LDL  was  filtered  to  determine  the 
background binding. In the absence of cells, filters bound between 2 and 5% of 
total counts. Filters were counted in scintillation fluid without further process- 
ing.  Determination  of cellular  protein  bound  to  filters  indicated  that  the 
numbers of cells trapped were highly reproducible. As the uptake approached 
equilibrium, the relative  differences  in  amounts of benzo(a)pyrene entering 
cells were small. To establish that differences  in cellular [3H]benzo(a)pyrene at 
the later time points were significantly  above background levels, aliquots of the 
reaction mixture were counted without filtering and compared with the cellular 
radioactivity at equilibrium. 
Fluorescence kinetic assays were performed in an SLM 8000 spectrofluori- 
meter (SLM Instruments, Inc., Urbana, IL) with stirred cell  suspensions in a 
temperature-regulated cuvette holder. Solutions of l-palmitoyl-2-oleoyl-phos- 
phatidylcholine  vesicles  containing  benzo(a)pyrene  plus  a  fluorescence 
quencher, N-2,4-dinitrophenyl-N,N-dioctadecylamine(16)  were added to sus- 
pensions of fibroblasts or P388Dz  cells.  Benzo(a)pyrene fluorescence intensity 
was recorded as a function of time using excitation and emission wavelengths 
of 365 nm and 407 nm, respectively. 
Analysis of kinetic data was performed by nonlinear least squares regression 
with respect to a monoexponential function. Data points were manually entered 
into an Apple 11 Plus microcomputer (Apple Computer, Inc., Cupertino, CA). 
The analytical  program involved a reiteritive  procedure and stringent criteria 
for convergence. Results of the analysis were evaluated by comparative plots of 
fitted curves and measured data points, standard deviation of data points from 
the fitted line, standard deviations for rate constant, and initial  and final values, 
and analysis of correlation of error in these parameters. 
RESULTS 
Normal human fibroblasts metabolized benzo(a)pyrene very 
slowly, if at all, as illustrated in Fig.  1 and Table I. Thus, the 
interpretation  of increase  in cellular  fluorescence,  as an ac- 
curate  index  of cellular  uptake  of benzo(a)pyrene,  is  not 
complicated  by  the  formation  of  metabolic  products. 
Benzo(a)pyrene metabolism was studied in parallel with C3H/ 
10T  1/2 mouse  fibroblasts,  which  have  been  shown  to  have 
significant benzo(a)pyrene metabolic capacity (35). C3H/10T 
1/2 cells produced fourfold more metabolites per milligram of 
cell protein in 24 h than did normal human fibroblasts.  Less 
than  5%  of the  radioactivity  was present  as metabolites  in 
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FIGURE  I  Benzo(a)pyrene metabolism  in  cultured  cells.  Normal 
human fibroblasts (@) and C3H/10T I/2 routine fibroblasts  (O) were 
incubated at 37°C  in the presence of 50 ~g/ml  -~  LDL containing 
[G-3H]benzo(a)pyrene.  A  total  of  10  nmol  benzo(a)pyrene  was 
added  to  each  plate.  For  each  cell  type,  duplicate  dishes were 
incubated for 2  h at 4°C.  Approximately 2% of total counts were 
identified as metabolites in these control plates.  Data are expressed 
as total nanomoles of metabolites recovered from cells and media, 
corrected  for the values at 4°C,  and  normalized per milligram of 
cell protein. 
TABLE  I 
Comparative Metabolism of Benzo(a)pyrene in Normal Human 
Fibroblasts and Murine C3HJ l OT Y2 Fibroblasts 
Incubation  BP in 
Cell type  time*  Cells  Media  metabolites 
Normal human 
fibroblast 
C3H/10T Y2  2 
4°C 
2 
nmol BP metabolites  %  of original 
37°C  mg  -~ protein  radioactivity 
0.11  0.58  2.5 
2  0.14  1.14  4.3 
10  0.14  0,91  3.8 
24  0.25  1.06  4.8 
0.14  0.68  2.3 
2  0.19  1.40  4.3 
10  0.33  1.99  5.6 
24  0.52  4.27  12.5 
BP, benzo(a)pyrene. 
* Time in hours. 
fibroblast dishes, in contrast to  12%  of total benzo(a)pyrene 
in C3H/10T  '/2 dishes in 24 h. P388D,  cells were also exam- 
ined for metabolic activity in a similar fashion, with negative 
results (data not shown). 
Benzo(a)pyrene was presented  to  cells  as  a  noncovalent 
component of LDL.  Benzo(a)pyrene was solubilized in the 
hydrophobic  core  of lipoproteins,  as  demonstrated  by  its 
fluorescence  spectrum  in  LDL  (Fig.  2).  When  the  same 
amount of benzo(a)pyrene in ethanolic solution was injected 
into aqueous buffer,  the spectrum revealed that most of the 
benzo(a)pyrene was present as microcrystalline aggregates. 
The cellular benzo(a)pyrene mass was obtained by quanti- 
fication  of [G-3H]benzo(a)pyrene  uptake.  Fig.  3  shows the 
result of cell filtration assays in which 1 x  10  6 cells in stirred 
suspensions  were  exposed  to  increasing  concentrations  of 
LDL labeled with [G-3H]benzo(a)pyrene. At the highest level 
of benzo(a)pyrene-LDL used, 5 mg of LDL protein, ml  -~ and 
1  mM  benzo(a)pyrene,  cellular  accumulation  of benzo(a)- 
pyrene from LDL was ~1.5  x  10  -~5 mol benzo(a)pyrene per 
ceil. With an estimated cell volume based on dimensions of 
40  x  30  ×  10  um,  this corresponds to an average cellular 
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concentration  of ~150  uM.  Benzo(a)pyrene  was  not  uni- 
formly distributed throughout any cell, however, and as will 
be described,  often  distinctly  accumulated in  regions com- 
prising only a fraction of the total cell volume. 
The time-dependent increase in the cellular fluorescence of 
benzo(a)pyrene is plotted in Fig. 4 for a typical experiment in 
which cells were exposed to 50 mg. ml-~ benzo(a)pyrene-LDL. 
Mean  intensity  values and  intensities corresponding to the 
brightest intracellular areas were within the limits of detection 
and the linear response range of the video camera as deter- 
mined by the fluorescence intensities of ethanolic solutions 
containing 0.1-200 gM benzo(a)pyrene. 
The uptake of benzo(a)pyrene from lipoproteins into cells 
was  independent  of endocytosis  of the  lipoprotein  carrier, 
even in cells that expressed receptors for LDL. Evidence for 
this was shown by the different rates of uptake of benzo(a)- 
pyrene and diI when both probes were incorporated into the 
same lipoprotein. Because of the differences in spectral prop- 
erties of the two probes, their cellular fluorescence was quan- 
tified independently.  Cellular uptake of benzo(a)pyrene oc- 
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Spectral characteristics  of benzo(a)pyrene solubilized in 
LDL  and  dispersed  as  microcrystals.  Spectrum  A  (  ):  10  #M 
benzo(a)pyrene as a component of LDL. Spectrum B (- -  -): 10 #M 
benzo(a)pyrene prepared by injection of a 1-mM ethanolic solution 
of benzo(a)pyrene into aqueous buffer. The intensity scale for A  is 
10-fold greater than for B. 
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FIGURE  3  Cellular  uptake  of  [G-3H]benzo(a)pyrene.  Increasing 
amounts  of  [G-3H]benzo(a)pyrene-LDL  were  added  to  2  ml  of 
stirred suspensions of 2 ×  106 P388D, macrophages. 50-#1 aliquots 
were taken after 20 rain to separate cells and incubation solution 
by filtration through glass fiber filters.  Background values of 1-5% 
of total counts were obtained for solutions without cells, and these 
values  were  subtracted  from  filter  counts.  Specific  activity  of 
benzo(a)pyrene  was  130  cpm.pmo1-1,  with  ~400  pmol  of 
benzo(a)pyrene per picomole of LDL. >, 
a 
p, 
® 
e- 
@ 
0 
@ 
Ilc 
FIGURE  4 
200 
100 
4- 
lllllll  I 
IAAA&&AAA&& 
20  4, 
°c;  '  ;  '  'o  '  '  '  '  1  15  20 
Time, rain 
Cellular accumulation of benzo(a)pyrene. Medium con- 
taining 50 #g. m1-1 benzo(a)pyrene-labeled LDL was added to via- 
ble human fibroblasts on the microscope stage. Fluorescence  inten- 
sity in a single field was sampled at the indicated times. Temperature 
was maintained at approximately 37°C.  Neutral-density filters at- 
tenuated excitation light to 1% of maximum. Mean intensities over 
the field (A), and upper range values for the field (11} are plotted as 
a function of time. Arrows at the abscissa designate limits of detec- 
tion and range of linearity as determined by calibration with ethan- 
olic solutions of  benzo(a)pyrene, which  were 0.1  and  200  aM, 
respectively. 
curred within  minutes and  remained unchanged after ~10 
min (Fig.  5), while cellular accumulation of the diI-labeled 
LDL required hours (Figs. 6 and 7). DiI has been shown to 
remain with LDL during the course of LDL endocytosis (29). 
Furthermore, when  fibroblasts,  which do not have specific 
receptors for HDL (l l), were exposed to HDL labeled with 
both  diI  and  benzo(a)pyrene,  the  time  course  of benzo- 
(a)pyrene uptake was the same as that observed with LDL, 
while essentially no diI fluorescence was  detected (Fig.  8). 
Fibroblasts, preincubated with lipoprotein-deficient medium' 
to induce  LDL receptors, did  not take  up benzo(a)pyrene 
faster or to a greater extent than noninduced cells. Cells fixed 
with  2%  formaldehyde  also  accumulated  benzo(a)pyrene 
from lipoproteins with the same rate and extent to produce 
the  same  pattern  of intraceUular localization as did viable 
cells examined in parallel. Cellular uptake and distribution of 
benzo(a)pyrene is therefore a spontaneous physical event that 
does  not  require metabolic processes,  and  the  rate  is  not 
influenced by the presence or absence of receptors for the 
lipoprotein carrier. 
The rate  of cellular uptake  of benzo(a)pyrene has been 
determined by three different techniques. Table Ii summarizes 
the  rate  constants  for incorporation of benzo(a)pyrene by 
living and fixed cells as a function of temperature, lipophilic 
donor, and  method of analysis.  With  digital  fluorescence- 
imaging microscopy, the fluorescence intensity of each pixel 
in the image was measured. Fig. 9 shows the time-dependent 
increase in mean cellular fluorescence. The data were ana- 
lyzed by nonlinear least squares regression with respect to a 
monoexponential function.  The rate  constants  for cellular 
accumulation was 0.39 rain -~ at 37°C and 0.25 rain  -~ at 23°C. 
To confirm the  rate constants measured by fluorescence 
microscopy, cell suspensions were mixed with l-palmitoyl-2- 
oleoyl-phosphatidylcholine  vesicles  containing  benzo(a)- 
pyrene  and  a  nonexchangeable  quencher,  N-2,4-dinitro- 
phenyl-N,N-dioctadecylamine. Increase in fluorescence inten- 
sity as a  function of time was followed in a  fluorimeter as 
benzo(a)pyrene transferred from quenched vesicles to cells. 
The rate constant for cellular uptake of benzo(a)pyrene was 
0.21 min-' at 21*C. Stirred cell suspensions were also mixed 
with LDL containing [G-3H]benzo(a)pyrene. Aliquots taken 
at selected time intervals were rapidly filtered through glass 
fiber filters to trap cells and associated benzo(a)pyrene. The 
rate constants determined with this method was about 0.29 
min  -~  at  25"C.  Experiments with  cells  in  suspension  per- 
formed with either fibroblasts or P388Dj macrophages gave 
identical results. Thus, regardless of method or cell type used, 
uptake  of benzo(a)pyrene into  cells  at  room  temperature 
occurs with a halftime of ~2 rain. Only digital fluorescence- 
imaging microscopy, however, demonstrated the topographic 
heterogeneity of the intracellular location of benzo(a)pyrene. 
The sampling area of this imaging microscopy system at 
the object plane was ~0.0625 um  2 per pixel. Analysis of the 
-increase in  fluorescence intensity with time was  performed 
on single pixels or small numbers of pixels corresponding to 
discrete intracellular locations and organelles. This analysis of 
the increase in benzo(a)pyrene fluorescence at discrete sub- 
cellular locations in  individual  cells did  not  identify any 
significant differences in  rate constants for benzo(a)pyrene 
accumulation. However, due to a combination of the limited 
modulation transfer function of the camera (36) and optical 
diffusion of fluorescence in a  light-scattering medium (i.e., 
cytoplasm),  this  question  cannot  be  resolved without  the 
application of computer-based mathematical deblurring pro- 
cedures (36). 
The amount of benzo(a)pyrene in different cellular loca- 
tions varied greatly as determined by fluorescence intensity 
(Figs.  5,  7,  and 8).  For reference, the relative fluorescence 
intensities of 10 #M benzo(a)pyrene at the emission maxi- 
mum of 405 nm were  1.0, 1.1, 1.3, and 2.0 in acetonitrile, 
ethanol, cyclohexane, and l-palmitoyl-2-oleoyl-phosphatidyl- 
choline vesicles, respectively. Because benzo(a)pyrene fluores- 
cence was a linear function of concentration, and the relative 
fluorescence intensity of benzo(a)pyrene in different hydro- 
phobic environments was similar, these results indicated that 
benzo(a)pyrene partitioned selectively into discrete subcellu- 
lar locations. 
LDL labeled with both benzo(a)pyrene and diI delivered 
both  probes  to  cells  simultaneously,  but  spatial  analysis 
showed that the intracellular locations of  the two fluorophores 
were distinctly different. The left panel of Fig.  10 (top left 
image)  shows  a  fibroblast  labeled  with  both  diI  and 
benzo(a)pyrene. The corresponding phase images are shown 
in the right panel of Fig.  10. The fluorescence images were 
viewed simultaneously by storing each image in a  separate 
memory plane. Superimposition of the benzo(a)pyrene fluo- 
rescence image on the diI fluorescence image demonstrated 
unequivocally the distinct locations of the two fluorophores. 
Identification  of  which  cellular  structures  accumulate 
benzo(a)pyrene was  achieved with  a  series  of experiments 
using different organelle-specific fluorescent probes. Endocy- 
tosis of LDL delivers diI to lysosomes (10).  Because diI is 
positively charged at low pH, it accumulates in these acidic 
compartments. To confirm the localization of diI, fibroblasts 
were grown in lipoprotein-deficient medium and then incu- 
bated with diI-labeled LDL for 2-4 h.  Live cells were then 
exposed to 5 gg. ml  -~ acridine orange to identify acidic com- 
partments (37).  The left center image of Fig.  8 (left) shows 
the  coincidence of DiI  and  acridine  orange  fluorescence, 
indicating  co-localization  in  acidic  intracellular  compart- 
ments. Benzo(a)pyrene fluorescence was not associated with 
PLANT ~'T AL.  Cellular Uptake of Benzo(a)pyrene and Low Density Lipoproteins  1299 FIGURE  5  Cellular accumulation of benzo(a)pyrene by viable cells. 50 ~.g-ml  -I LDL containing either dil or benzo(a)pyrene  was 
added in medium to ceils on the microscope stage at 37°C. At the times indicated, cells were exposed for I  s to excitation light 
attenuated to I% for benzo(a)pyrene and 60% for dil. Cells had been preincubated for 2 d  in lipoprotein-deficient medium to 
induce the expression of LDL receptors. (Left images) Benzo(a)pyrene  fluorescence at 0.017,  I, 2, and 4 rain, respectively. (Right) 
The  isometric projections (22)  illustrate the  pixel-by-pixel time-dependent increases  in  intensity values  for  benzo(a)pyrene 
fluorescence. The corresponding digital images are immediately  to the left of each projection. 
1300 FIGURE 6  Cellular accumulation of LDL by viable cells. The experimental  conditions are described in the legend to Fig. 5, except 
the excitation light was attentuated 60% to observe dil without photobleaching. (Left images) DiI-LDL fluorescence at 5, 15, 30, 
and 60 min, respectively.  (Right) The isometric projections (22) illustrate the pixel-by-pixel  time-dependent increases in intensity 
values for dil fluorescence. The corresponding digital images are immediately to the left of each projection. 
1301 FIGURES 7 and 8  Comparison of benzo(a)pyrene uptake from HDL and LDL. Normal human fibroblasts on glass  coverslips were 
preincubated in lipid-deficient medium for 2 d, and then incubated for 4 h at 37°C with medium containing either LDL or HDL. 
The lipoproteins were labeled with both dil and benzo(a)pyrene.  Final benzo(a)pyrene concentration was 2.1  /~M. Dil labeling 
was ~6 molecules per HDL and ~18 per LDL. LDL concentration was 30/~g-m1-1 and HDL concentration was 182/~g-ml -~. Cells 
were washed three times with 0.04 M Tris (pH 7.4)  containing 5 mg. ml  -~ bovine serum albumin, fixed, and placed in a Bionique 
chamber for viewing. Excitation  light was attenuated to 5% for benzo(a)pyrene  uptake and to 40% for diI-LDL uptake.  The 
derivative images were obtained by subtraction  of the appropriate shifted  images from the original images and displaying the 
differences. The shifted images were created by incrementing the x,y coordinates of each pixel by 3 to the right and 3 to the top. 
Fig. 7 (left images) (top  to bottom)  Benzo(a)pyrene fluorescence,  the derivative image of benzo(a)pyrene fluorescence,  and the 
phase image of the cells, respectively.  (Right images) (top and bottom) dii fluorescence  of LDL, and the derivative image of dil 
fluorescence, respectively. Fig. 8 (Left images) (top to bottom) Benzo(a)pyrene fluorescence, the derivative  image of benzo(a)pyrene 
fluorescence,  and the phase image of the cells, respectively.  (Right images) (top and bottom) dil fluorescence  of HDL,  and the 
derivative image of dil fluorescence,  respectively. 
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acridine orange fluorescence (Fig.  10, left bottom image). 
The location of benzo(a)pyrene fluorescence was also com- 
pared with that of two other vital fluorescence probes, rho- 
damine-123 which is specific for mitochondria (38),  and  a 
cholesterol analog, NBD-cholesterol (27). From inspection of 
the images in the left panel of Fig.  10, it is apparent that 
FIGURE  9  Kinetics of benzo(a)pyrene uptake by viable fibroblasts. 
At  time  zero,  medium  containing  50  /~g.m1-1  benzo(a)pyrene-la- 
beled  LDL  was added  to  fibroblasts  at  37°C  on  the  microscope 
stage. Open circles represent mean fluorescence intensities for the 
field  containing  1-3  cells  at  the  indicated  times.  The  solid  line 
represents analysis of the data with respect to a  monoexponential 
function. The rate constant for uptake was 0.39 min  -1. 
PLAN1 Er ^L.  Cellular Uptake of Benzo(a)pyrene  and Low Density Lipoproteins  1303 1304  THE  JOURNAL  OF  CELL  BIOLOGY  • VOLUME  100,  1985 FIGURE 10  Comparison of spatial distribution of benzo(a)pyrene  fluorescence  in fibroblasts  with fluorescence  of Dil, acridine 
orange,  rhodamine-123, and NBD-cholesterol. Fibroblasts induced for LDL receptors  were incubated for 6 h at 37°C  in the 
presence of 50/~g.ml  -I LDL containing both benzo(a)pyrene and dil. Cells were washed 2 times with 0.15 M  NaCl and fixed 
with 2% formaldehyde before viewing. Labeling procedures  used with the other fluorescent probes are described  in Materials 
and Methods. To compare the distribution of two fluorescent probes, the phase images for the respective  fluorescent images 
were superimposed by computer alignment of two memory planes. This procedure was necessary to  correct misalignment 
originating from the nonparfocal nature of the filter cubes.  Either a red or blue-green color was assigned to the two image 
channels for display of the fluorescence images identified below. With this combination of pseudocolors,  regions of overlapping 
intensity in each image appear in white. The horizontal cursor identifies the pixel rows, the fluorescence intensity values of which 
are displayed as either a red or white intensity profile at the bottom of each panel. (Left page)  (left top images)  Dil (red color and 
red  intensity profile), benzo(a)pyrene (blue-green color and white intensity  profile).  (Left center  images)  Dil (red color and  red 
intensity profile),  acridine orange (blue-green color and white intensity profile).  (Left bottom images) Acridine orange (red color 
and red intensity profile),  benzo(a)pyrene (blue-green  color and white intensity profile).  (Right  top images)  Rhodamine-123 (red 
color and  red  intensity profile), benzo(a)pyrene (blue-green  color and white intensity  profile).  (Right  bottom  images)  NBD-- 
cholesterol (red color and red intensity profile),  benzo(a)pyrene  (blue-green color and white intensity  profile).  (Right page). The 
phase images correspond to their respective superimposed  fluorescence  images on the facing page. Bar, I0 p.m. 
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Rate Constants for Uptake and Efflux of Benzo(a)pyrene by 
Human Fibroblasts 
Tempera-  Cell 
ture  k  condition  Method* 
°C  min  -~ 
Donors 
LDL  37  0.39 (+0.04)  live  a 
22  0.29 (+0.03)  fixed  a 
23  0.25 (+0.08)  live  b 
HDL  37  0.34 (+0.08)  live  a 
21  0.32 (__+0.04)  fixed  a 
26  0.29 (___0.03)  live  b 
VLDL  26  0.33 (__+0.04)  live  b 
POPC vesicles  21  0.21  (+0.03)  live  c 
Acceptors 
HDL  22  0.26 ('___0.04)  fixed  a 
POPC  37  0.34 (+0.03)  live  c 
The values in parentheses are standard deviations of data points from their 
fitted  curves.  The  vesicles  were  1-palmitoyl-2-oleylphosphatidylcholine 
(POPC). 
* a, fluorescence microscopy; b, spectrofluorimetry; c, [G-3H]benzo(a)pyrene 
filler assay. 
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FIGURE 11  Relationship of cellular neutral  lipid  content,  [G-3H] - 
benzo(a)pyrene uptake, and  benzo(a)pyrene fluorescence. Mouse 
peritoneal macrophages were incubated for 38 h  with 50 pg.m1-1 
LDL, acLDL,  or htg VLDL,  in addition to [1J4C]oleate complexed 
with bovine serum albumin. Cells were then incubated for 1 h with 
[G-SH]benzo(a)pyrene-LDL.  Quantification  of  [1J4C]-oleate  and 
[G-3H]-benzo(a)pyrene  in  cells  grown  in  parallel  is  described  in 
Materials  and  Methods.  The  fluorescence  intensity  of  cells  on 
coverslips was digitized with a gray scale of 0-255.  Height of the 
striped bar represents upper range intensity values for each image, 
and arrows designate mean intensity values for the entire field. The 
open  and  closed  bars  represent  the  amount  of  triglyceride  and 
cholesteryl ester,  respectively, in  the  neutral  lipid  fraction  of the 
cell extract. 
TABLE III 
Effect of Intracellular Lipid on Benzo(a)pyrene Accumulation 
Lipo-  Fluorescence 
protein in  intensity 
preincu-  Ben- 
bation  Triglycer-  Cholesteryl  zo(a)-  Upper 
medium  ide  ester  pyrene  Mean  range 
pmol [ l-14C]oleate mg  -~  nmol rag-' 
protein  protein 
LDE  67  0.8  10  13  66 
acLDL  85  66  12  18  150 
htg VLDL  210  3  15  46  240 
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FiGUrE  12  Equilibrium  distribution  of  benzo(a)pyrene  between 
cells and LDL as a function of extracellular LDL concentration. LDL 
(0.5 #g) containing 100 pmol [G-3H]benzo(a)pyrene was added to 
1 ml of a stirred cell suspension containing 106 cells and indicated 
amounts  of  unlabeled  LDL.  After  20  min  at  room  temperature, 
aliquots were  removed and  filtered.  Cells retained on glass  fiber 
filters were counted to quantify cellular uptake of benzo(a)pyrene. 
rhodamine-123 and benzo(a)pyrene did not distribute in the 
same intracellular location (top right), but that NBD-choles- 
terol and benzo(a)pyrene  were distinctly co-localized (bottom 
right). 
The co-localization of benzo(a)pyrene  and the fluorescent 
cholesterol  analog  suggests  that  benzo(a)pyrene  partitions 
selectively  into  cytoplasmic  lipid  droplets.  Partitioning  of 
benzo(a)pyrene  into intracellular  lipid droplets  is not unex- 
pected,  in view of its lipophilic nature.  Moreover,  benzo(a)- 
pyrene  has been used previously as a cytochemical stain for 
lipid (39).  Because of the partitioning  of benzo(a)pyrene,  in- 
tracellular  accumulation  of lipid  should  produce  increased 
benzo(a)pyrene  accumulation. To demonstrate this relation- 
ship,  mouse  peritoneal  macrophages  were  incubated  with 
acLDL (34) or htg VLDL (25), lipoproteins that produce large 
intracellular accumulations of cholesteryl  ester or triglyceride 
in these cells, respectively.  Cells incubated with acLDL incor- 
porated  ~6.6  pmol  and  8.5  pmol-mg -I  protein  of [1J4C] 
oleate into  cholesteryl  esters  and triglycerides,  respectively. 
Cells incubated with htg VLDL incorporated  3.0 pmol and 
210  pmol. mg  -J  protein [IJ4C]oleate  into cholesteryl  esters 
and triglycerides, respectively. The amount of benzo(a)pyrene 
incorporated  by  these  cells  increased  with  increased  lipid 
accumulated,  measured  by  [G-3H]benzo(a)pyrene  and  by 
cellular  fluorescence  intensity  (Fig.  1 l;  Table  III). After 
preincubation  with acLDL, 24 nmol benzo(a)pyrene  was ac- 
cumulated per nanomole [ IJ4C]oleate  esterified. After prein- 
cubation  with  htg  VLDL,  cells  accumulated  34  nmol 
benzo(a)pyrene  per nanomole [ IJ4C]oleate  esterified. 
When LDL labeled with [G-3H]benzo(a)pyrene  was added 
to cell suspensions containing increasing  concentrations  of 
unlabeled  LDL, the rate constants for benzo(a)pyrene  uptake 
were  unchanged.  However,  the  net  amount  of  cellular 
benzo(a)pyrene  decreased as a function of increasing amount 
of unlabeled  LDL added  to the extracellular  solution (Fig. 
12). Thus, the equilibrium distribution of benzo(a)pyrene  into 
cells was controlled by the relative lipid volume of cells and 
extracellular particles. 
DISCUSSION 
Mechanism of Cellular Uptake 
The importance of partitioning  and solubility characteris- 
tics  of carcinogenic  compounds  on  their  distribution  and 
metabolism has been  largely  ignored.  Consideration of the physical properties of polycyclic aromatic hydrocarbons sug- 
gests that it is reasonable to expect benzo(a)pyrene metabo- 
lism would be influenced by its lipid solubility and partition- 
ing into membranes and lipid droplets. It has been noted (40- 
42)  that  the  apparent  Km  measured  for  cytochrome P45o 
substrates is dependent on concentrations of membranes or 
cells. Recently, Backes et al. (43) addressed the mechanism of 
this phenomenon by calculating microsomal partition coeffi- 
cients for a series of aromatic substrates of increasing molec- 
ular size. Nemoto and Takayama (44) found that the addition 
of serum to microsome suspensions resulted in large increases 
in  benzo(a)pyrene metabolism,  at  least in  part  due to in- 
creased solubilization of benzo(a)pyrene. 
In most metabolic studies, either in purified reconstituted 
P45o systems or in cell culture, benzo(a)pyrene is usually added 
as a concentrated solution in organic solvent (45,  46).  The 
observation  of crystalline benzo(a)pyrene in  lysosomes of 
fibroblasts,  which involved the addition of benzo(a)pyrene at 
high concentrations in dimethylsulfoxide to the culture me- 
dium, most likely involved phagocytosis of particulate hydro- 
carbon.  Spectral analysis of benzo(a)pyrene (3,  4) demon- 
strates that benzo(a)pyrene is dispersed as microcrystals by 
this  method.  Lakowicz et al.  (5)  have  shown  significantly 
slower rates of solubilization of benzo(a)pyrene from micro- 
crystals to membranes, compared with the rates for benzo- 
(a)pyrene solubilized by adsorption to particulate material. 
Thus, any kinetic data for benzo(a)pyrene metabolism involv- 
ing this mechanism of presentation is therefore difficult, if 
not impossible, to interpret. In this study we have avoided 
this  experimental  ambiguity  by  presenting  cells  with 
benzo(a)pyrene solubilized in the hydrophobic core of  plasma 
lipoproteins. 
It has been shown (6) that benzo(a)pyrene in  plasma  is 
associated with lipoproteins, and to the greatest extent with 
LDL in normolipemic plasma. By exposing both living and 
fixed cells to LDL containing benzo(a)pyrene, we have shown 
by digital fluorescence microscopy that the cellular uptake of 
benzo(a)pyrene occurs at the same rate and is therefore in- 
dependent of LDL endocytosis. This conclusion supports the 
work of Remsen and Shireman (20), who compared benzo(a)- 
pyrene  uptake  from  LDL  by  both  normal  and  receptor- 
negative  fibroblasts,  at  single  time  points.  Although  these 
authors did  not  exclude low  affinity receptor-independent 
pathways, they correctly concluded that a  passive diffusion 
process was  responsible  for benzo(a)pyrene transfer to the 
plasma membrane. In the present study, digital fluorescence 
microscopy provides topographic information about the in- 
traceUular location of benzo(a)pyrene. Thus, mechanistically, 
passive transfer appears to be solely responsible for redistri- 
bution of benzo(a)pyrene from extracellular lipoproteins to 
the plasma membrane, and from the plasma membrane to 
intracellular compartments. The time course of uptake and 
the  intracellular localization  of benzo(a)pyrene are  clearly 
independent of that of the lipoprotein particle as indicated by 
the nontransferable fluorescent lipoprotein probe, diI. 
The results from this investigation are not consistent with 
the  conclusions  reached  by  Shu  and  Bymun  (47).  These 
authors reported that the amount of benzo(a)pyrene excreted 
in the bile of rats injected with benzo(a)pyrene noncovalently 
associated with lipoproteins was dependent on the lipoprotein 
donor with which benzo(a)pyrene was originally associated. 
However, equilibration of benzo(a)pyrene among plasma li- 
poprotein classes occurs on a millisecond time scale (13). In 
that this equilibration is two orders of magnitude faster than 
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benzo(a)pyrene entry into cells, rate constants for cell uptake 
and release of benzo(a)pyrene should be independent of the 
identity of the original lipoprotein donor, which we observe. 
Intracellular Location of Benzo(a)pyrene 
Intracellular location of  benzo(a)pyrene has been compared 
with that of various fluorescent probes with known intracel- 
lular  locations.  These  experiments  indicate  that  benzo(a)- 
pyrene is not predominantly located in acidic compartments 
or mitochondria, but concentrates in cytoplasmic lipid drop- 
lets (48,  49),  as expected from its solubility properties and 
intracellular coincidence with a cholesterol analog. It should 
be noted that benzo(a)pyrene fluorescence is conspicuously 
absent  from  the  nucleus.  It  is  not  possible,  at  present,  to 
distinguish between fluorescence quenching and the presence 
of benzo(a)pyrene concentrations that are below the limits of 
detection. It seems unlikely that quenching accounts for the 
absence  of benzo(a)pyrene fluorescence.  Studies  involving 
removal and replacement of nucleic acids and treatment of 
tissue with ethanol  or buffers did  not produce measurable 
effect on fluorescence intensity (50, 51 ). 
Other  attempts  to  identify the  intracellular  location  of 
benzo(a)pyrene have employed subcellular fractionation (52- 
57).  This method gives  questionable results because of the 
rapid rate of benzo(a)pyrene partitioning.  Autoradiography 
of subcellular locations of polycyclic aromatic hydrocarbons 
carcinogens suggest that these compounds associate with cell 
nuclei (57-59). However, the comprehensive study by Shires 
(50) of the effects of various preparative procedures showed 
that benzo(a)pyrene fluorescence in  the  nucleus cannot be 
detected  except  when  ethanol,  citrate,  or  acetate  is  used. 
Moreover, nuclear fluorescence was detected by Stora (60) in 
tissue  sections from  rats  treated  with  benzo(a)pyrene only 
after 43 d. No nuclear fluorescence was detected before that 
time.  These  latter  experiments  involved  embedding  fixed 
tissue sections in paraffin, and deparaffinizing before viewing. 
Inasmuch as the solvents used for these experiments would 
remove all noncovalently bound benzo(a)pyrene, the nuclear 
fluorescence observed by  Stora  was  not  that  of benzo(a)- 
pyrene, but more likely a covalently immobilized metabolite 
of  benzo(a)pyrene. The predominant intracellular location for 
benzo(a)pyrene reported in our study is consistent with its 
partitioning characteristics. 
Transfer of benzo(a)pyrene between lipoprotein particles is 
two to three orders of magnitude faster than uptake by cells. 
The fact that the rate constants for cell uptake are the same, 
regardless  of carrier size,  suggests  that the slow  step in the 
entry of benzo(a)pyrene into  cells  occurs  after the  initial 
desorption  process.  Identification  of the  slow  step  in  the 
process of cell uptake of benzo(a)pyrene is still under inves- 
tigation, but it appears that the plasma membrane is the site 
of the  rate-limiting step  in  the accumulation of polycyclic 
aromatic hydrocarbons by cells. 
Increasing  the  concentration  of extracellular  unlabeled 
LDL  does  not  alter  the  rate  constant  for  benzo(a)pyrene 
uptake, but does decrease the net amount of benzo(a)pyrene 
entering cells.  By contrast,  increasing the  amount of lipid 
present in  cells  produces increased cellular benzo(a)pyrene 
accumulation. Moreover, it is apparent that benzo(a)pyrene 
uptake by cells is a spontaneous transfer process from a donor 
hydrophobic particle to cellular lipid compartments. Sponta- 
neous aqueous phase transfer is controlled by partitioning of 
the transferring species  between one hydrophobic compart- 
ment and another. The extent of transfer of benzo(a)pyrene 
ET  AL.  Cellular Uptake of Benzo(a~pyrene  and Low Density Lipoproteins  1307 into cells is determined by the equilibrium distribution be- 
tween the relative hydrophobic volumes inside and outside 
the cell. Increasing cellular lipid content in vivo could result 
in increased benzo(a)pyrene accumulation in tissues and in- 
dicates a  possible relationship between tissue lipid deposits 
and carcinogenesis. 
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